FYERS
Home
/
Stocks
/
Results
/
Emcure Pharmaceuticals Results

Emcure Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
8%9%15%17%
5%19%20%33%
---35%
18%23%20%20%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
EMCURE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,903.5₹456833 Cr37.7712.0762.82₹11479 Cr
9,181.5₹245426 Cr83.9134.04128.41₹2568 Cr
4,900₹187320 Cr85.8916.7297.06₹2163 Cr
1,135.7₹113217 Cr25.099.4262.53₹5040 Cr
1,390.8₹112212 Cr33.299.7757.87₹3879 Cr
1,850.9₹101155 Cr92.526.829.25₹889 Cr
2,124.5₹97626 Cr17.6630.95154.36₹5333 Cr
2,351₹96859 Cr47.4213.7571.08₹1913 Cr
1,164.6₹96406 Cr29.925.3263.99₹4196 Cr
1,653₹93614 Cr25.2217.9596.84₹3505 Cr
1,918.9₹35248 Cr34.8515.575.72₹924 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
₹2580 Cr₹2470 Cr₹2363 Cr₹2270 Cr₹2101 Cr₹2116 Cr₹1963 Cr₹2002 Cr₹1815 Cr₹1771 Cr₹1668 Cr₹1663 Cr₹1556 Cr
₹2 Cr₹4 Cr₹2 Cr₹39 Cr₹4 Cr₹4 Cr₹4 Cr₹36 Cr₹23 Cr₹12 Cr₹16 Cr₹1 Cr₹15 Cr
₹2583 Cr₹2474 Cr₹2365 Cr₹2309 Cr₹2104 Cr₹2121 Cr₹1967 Cr₹2038 Cr₹1838 Cr₹1784 Cr₹1683 Cr₹1664 Cr₹1571 Cr
₹2157 Cr₹2096 Cr₹1975 Cr₹1935 Cr₹1783 Cr₹1811 Cr₹1705 Cr₹1718 Cr₹1572 Cr₹1551 Cr₹1445 Cr₹1404 Cr₹1328 Cr
₹535 Cr₹484 Cr₹495 Cr₹479 Cr₹420 Cr₹407 Cr₹359 Cr₹417 Cr₹360 Cr₹323 Cr₹323 Cr₹330 Cr₹311 Cr
₹32 Cr₹46 Cr₹38 Cr₹33 Cr₹27 Cr₹39 Cr₹32 Cr₹46 Cr₹59 Cr₹65 Cr₹61 Cr₹59 Cr₹52 Cr
₹394 Cr₹341 Cr₹314 Cr₹341 Cr₹291 Cr₹261 Cr₹230 Cr₹273 Cr₹207 Cr₹167 Cr₹171 Cr₹198 Cr₹191 Cr
₹292 Cr₹244 Cr₹231 Cr₹251 Cr₹215 Cr₹197 Cr₹156 Cr₹202 Cr₹153 Cr₹121 Cr₹120 Cr₹146 Cr₹141 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2011Mar 2010Mar 2009Mar 2008
————————————————
₹190 Cr₹189 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹181 Cr₹45 Cr₹35 Cr₹49 Cr₹49 Cr₹49 Cr
₹12 Cr₹12 Cr₹14 Cr₹15 Cr₹16 Cr₹12 Cr₹27 Cr₹15 Cr₹16 Cr₹14 Cr₹9 Cr₹0₹0₹0₹0₹0
₹4748 Cr₹4245 Cr₹2757 Cr₹2305 Cr₹1791 Cr₹2080 Cr₹1704 Cr₹1639 Cr₹1504 Cr₹1387 Cr₹1202 Cr₹922 Cr₹402 Cr₹319 Cr₹136 Cr₹280 Cr
₹4748 Cr₹4245 Cr₹2757 Cr₹2305 Cr₹1791 Cr₹2080 Cr₹1704 Cr₹1639 Cr₹1504 Cr₹1378 Cr₹1194 Cr₹913 Cr₹402 Cr₹319 Cr₹136 Cr₹280 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹8 Cr₹8 Cr₹8 Cr₹6 L₹8 L₹10 L₹12 L
₹4950 Cr₹4446 Cr₹2952 Cr₹2501 Cr₹1988 Cr₹2273 Cr₹1912 Cr₹1835 Cr₹1701 Cr₹1582 Cr₹1393 Cr₹967 Cr₹437 Cr₹368 Cr₹185 Cr₹329 Cr
₹27 Cr₹195 Cr₹169 Cr₹149 Cr₹127 Cr₹95 Cr₹72 Cr₹65 Cr₹54 Cr₹67 Cr₹61 Cr₹47 Cr₹14 Cr₹10 Cr₹9 Cr₹7 Cr
₹250 Cr₹186 Cr₹761 Cr₹737 Cr₹709 Cr₹694 Cr₹541 Cr₹674 Cr₹790 Cr₹951 Cr₹910 Cr₹381 Cr₹311 Cr₹165 Cr₹153 Cr₹148 Cr
₹2 Cr₹4 Cr₹5 Cr₹7 Cr₹9 Cr₹10 Cr₹12 Cr₹14 Cr₹15 Cr₹19 Cr₹18 Cr₹13 Cr₹3 Cr₹0₹0₹0
-₹41 Cr₹9 Cr₹41 Cr-₹60 Cr-₹73 Cr-₹108 Cr-₹157 Cr-₹137 Cr-₹155 Cr-₹170 Cr-₹147 Cr₹22 Cr₹32 Cr₹13 Cr-₹67 Cr₹16 Cr
₹331 Cr₹565 Cr₹527 Cr₹181 Cr₹182 Cr₹221 Cr₹444 Cr₹390 Cr₹299 Cr₹271 Cr₹260 Cr₹44 Cr₹93 Cr₹22 Cr₹23 Cr₹19 Cr
₹43 Cr₹48 Cr₹43 Cr₹40 Cr₹42 Cr₹66 Cr₹58 Cr₹56 Cr₹48 Cr₹56 Cr₹16 Cr₹73 Cr₹13 Cr₹94 Cr₹256 Cr₹8 Cr
₹584 Cr₹812 Cr₹1377 Cr₹905 Cr₹868 Cr₹883 Cr₹899 Cr₹997 Cr₹998 Cr₹1126 Cr₹1057 Cr₹534 Cr₹451 Cr₹294 Cr₹366 Cr₹191 Cr
————————————————
₹1808 Cr₹1480 Cr₹1309 Cr₹1086 Cr₹1125 Cr₹972 Cr₹741 Cr₹685 Cr₹622 Cr₹506 Cr₹505 Cr₹513 Cr₹169 Cr₹153 Cr₹109 Cr₹82 Cr
₹1094 Cr₹547 Cr₹855 Cr₹712 Cr₹649 Cr₹972 Cr₹715 Cr₹640 Cr₹698 Cr₹645 Cr₹518 Cr₹391 Cr₹192 Cr₹139 Cr₹126 Cr₹90 Cr
₹795 Cr₹475 Cr₹947 Cr₹1132 Cr₹1085 Cr₹1253 Cr₹1271 Cr₹1087 Cr₹763 Cr₹470 Cr₹379 Cr₹334 Cr₹109 Cr₹158 Cr₹174 Cr₹99 Cr
₹215 Cr₹167 Cr₹99 Cr₹89 Cr₹106 Cr₹211 Cr₹193 Cr₹130 Cr₹254 Cr₹195 Cr₹328 Cr₹170 Cr₹21 Cr₹29 Cr₹49 Cr₹36 Cr
₹3912 Cr₹2668 Cr₹3210 Cr₹3019 Cr₹2965 Cr₹3408 Cr₹2920 Cr₹2543 Cr₹2336 Cr₹1817 Cr₹1731 Cr₹1408 Cr₹491 Cr₹479 Cr₹459 Cr₹308 Cr
₹9473 Cr₹8122 Cr₹7709 Cr₹6573 Cr₹5947 Cr₹6659 Cr₹5803 Cr₹5440 Cr₹5089 Cr₹4592 Cr₹4241 Cr₹2957 Cr₹1394 Cr₹1151 Cr₹1018 Cr₹836 Cr
₹259 Cr₹394 Cr₹286 Cr₹97 Cr₹12 Cr₹13 Cr₹14 Cr₹13 Cr₹16 Cr₹20 Cr₹17 Cr₹22 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr
₹1204 Cr₹732 Cr₹2072 Cr₹2182 Cr₹2077 Cr₹2310 Cr₹2170 Cr₹2128 Cr₹1988 Cr₹1815 Cr₹1567 Cr₹992 Cr₹526 Cr₹410 Cr₹416 Cr₹303 Cr
————————————————
₹6005 Cr₹5438 Cr₹5092 Cr₹3802 Cr₹3472 Cr₹3932 Cr₹3561 Cr₹3105 Cr₹2635 Cr₹2317 Cr₹2020 Cr₹1896 Cr₹848 Cr₹632 Cr₹538 Cr₹432 Cr
₹2686 Cr₹2241 Cr₹1968 Cr₹1656 Cr₹1428 Cr₹1476 Cr₹1179 Cr₹857 Cr₹586 Cr₹376 Cr₹167 Cr₹767 Cr₹193 Cr₹140 Cr₹99 Cr₹64 Cr
₹0₹0₹0₹0₹0₹44 Cr₹0₹93 L₹0₹0₹0₹0₹0₹0₹0₹0
₹3319 Cr₹3197 Cr₹3125 Cr₹2147 Cr₹2044 Cr₹2412 Cr₹2382 Cr₹2247 Cr₹2049 Cr₹1941 Cr₹1853 Cr₹1129 Cr₹655 Cr₹492 Cr₹438 Cr₹368 Cr
₹172 Cr₹124 Cr₹132 Cr₹404 Cr₹310 Cr₹222 Cr₹332 Cr₹422 Cr₹494 Cr₹385 Cr₹98 Cr₹78 Cr₹57 Cr₹149 Cr₹161 Cr₹60 Cr
₹20 Cr₹19 Cr₹18 Cr₹25 Cr₹25 Cr₹30,000₹30,000₹40,000₹10,000₹32 L₹32 L₹40,000₹3 L₹3 L₹3 L₹53 L
₹20 Cr₹19 Cr₹18 Cr₹25 Cr₹25 Cr₹30,000₹30,000₹40,000₹10,000₹32 L₹32 L₹40,000₹3 L₹3 L₹3 L₹53 L
₹236 Cr₹161 Cr₹144 Cr₹114 Cr₹112 Cr₹219 Cr₹220 Cr₹110 Cr₹125 Cr₹166 Cr₹103 Cr₹168 Cr₹58 Cr₹40 Cr₹32 Cr₹67 Cr
₹14 Cr₹12 Cr₹4 Cr₹40 Cr₹22 Cr₹9 Cr₹14 Cr₹50 Cr₹48 Cr₹40 Cr₹13 Cr₹5 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr
₹3861 Cr₹3566 Cr₹3449 Cr₹2737 Cr₹2523 Cr₹2942 Cr₹3100 Cr₹2987 Cr₹2753 Cr₹2587 Cr₹2131 Cr₹1401 Cr₹858 Cr₹733 Cr₹669 Cr₹514 Cr
————————————————
₹0₹76 Cr₹300 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹50 L₹0
₹2398 Cr₹1932 Cr₹1525 Cr₹1383 Cr₹1449 Cr₹1514 Cr₹1173 Cr₹1128 Cr₹928 Cr₹995 Cr₹912 Cr₹626 Cr₹206 Cr₹169 Cr₹125 Cr₹136 Cr
₹2563 Cr₹2002 Cr₹1859 Cr₹1648 Cr₹1309 Cr₹1475 Cr₹1145 Cr₹972 Cr₹870 Cr₹642 Cr₹752 Cr₹608 Cr₹249 Cr₹183 Cr₹173 Cr₹142 Cr
₹148 Cr₹165 Cr₹232 Cr₹458 Cr₹313 Cr₹524 Cr₹164 Cr₹104 Cr₹270 Cr₹263 Cr₹313 Cr₹217 Cr₹21 Cr₹21 Cr₹10 Cr₹6 Cr
₹105 Cr₹85 Cr₹99 Cr₹79 Cr₹86 Cr₹34 Cr₹34 Cr₹40 Cr₹46 Cr₹19 Cr₹31 Cr₹12 Cr₹5 Cr₹3 Cr₹2 Cr₹2 Cr
₹399 Cr₹295 Cr₹239 Cr₹268 Cr₹267 Cr₹170 Cr₹187 Cr₹208 Cr₹220 Cr₹85 Cr₹102 Cr₹93 Cr₹56 Cr₹41 Cr₹37 Cr₹36 Cr
₹5612 Cr₹4556 Cr₹4254 Cr₹3836 Cr₹3424 Cr₹3717 Cr₹2703 Cr₹2453 Cr₹2335 Cr₹2005 Cr₹2110 Cr₹1555 Cr₹536 Cr₹418 Cr₹349 Cr₹322 Cr
₹1700 Cr₹1888 Cr₹1044 Cr₹817 Cr₹459 Cr₹309 Cr-₹217 Cr-₹90 Cr-₹94 L₹188 Cr₹379 Cr₹147 Cr₹45 Cr-₹61 Cr-₹110 Cr₹14 Cr
₹9473 Cr₹8122 Cr₹7709 Cr₹6573 Cr₹5947 Cr₹6659 Cr₹5803 Cr₹5440 Cr₹5089 Cr₹4592 Cr₹4241 Cr₹2957 Cr₹1394 Cr₹1151 Cr₹1018 Cr₹836 Cr
₹260₹234₹162₹137₹109₹125₹104₹101₹93₹86₹76₹212₹124₹113₹54₹101
₹260₹234₹162₹137₹109₹125₹104₹101₹93₹86₹76₹53₹31₹28₹14₹25

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2011Mar 2010Mar 2009Mar 2008
₹1287 Cr₹971 Cr₹727 Cr₹747 Cr₹973 Cr₹657 Cr₹105 Cr₹331 Cr₹290 Cr₹296 Cr₹770 Cr₹370 Cr₹119 Cr₹290 Cr-₹218 Cr-₹2 Cr
₹555 Cr₹552 Cr₹543 Cr₹492 Cr₹399 Cr₹582 Cr₹611 Cr₹397 Cr₹411 Cr₹392 Cr₹290 Cr₹505 Cr₹116 Cr-₹71 Cr₹367 Cr₹72 Cr
-₹530 Cr-₹424 Cr₹51 Cr-₹292 Cr-₹292 Cr-₹335 Cr-₹124 Cr-₹149 Cr-₹166 Cr-₹94 Cr-₹331 Cr-₹180 Cr-₹103 Cr-₹47 Cr-₹16 Cr₹7 Cr
₹1312 Cr₹1099 Cr₹1321 Cr₹947 Cr₹1079 Cr₹905 Cr₹592 Cr₹579 Cr₹535 Cr₹593 Cr₹729 Cr₹696 Cr₹132 Cr₹172 Cr₹134 Cr₹77 Cr
₹944 Cr₹852 Cr₹1097 Cr₹747 Cr₹768 Cr₹704 Cr₹500 Cr₹444 Cr₹482 Cr₹460 Cr₹436 Cr₹523 Cr₹108 Cr₹149 Cr₹123 Cr₹55 Cr
-₹1193 Cr-₹94 Cr-₹713 Cr-₹468 Cr-₹789 Cr-₹252 Cr-₹164 Cr-₹409 Cr-₹426 Cr-₹616 Cr-₹689 Cr-₹431 Cr-₹168 Cr-₹106 Cr-₹170 Cr-₹101 Cr
₹343 Cr-₹814 Cr-₹164 Cr-₹145 Cr-₹152 Cr-₹189 Cr-₹301 Cr-₹735 Cr-₹69 Cr₹293 Cr₹303 Cr-₹250 Cr₹57 Cr-₹30 Cr₹52 Cr₹18 Cr
₹94 Cr-₹56 Cr₹221 Cr₹134 Cr-₹172 Cr₹264 Cr₹36 Cr-₹699 Cr-₹13 Cr₹137 Cr₹51 Cr-₹158 Cr-₹3 Cr₹12 Cr₹5 Cr-₹29 Cr
-₹14 Cr₹44 Cr-₹175 Cr-₹308 Cr-₹350 Cr-₹609 Cr-₹641 Cr₹59 Cr₹71 Cr-₹66 Cr-₹129 Cr₹344 Cr₹21 Cr₹9 Cr₹3 Cr₹32 Cr
₹0₹0₹0₹0₹214 Cr₹0₹0₹0₹0₹0₹13 Cr₹18 Cr₹0₹0₹0₹0
₹18 Cr-₹2 Cr-₹2 Cr-₹13 L₹19 L-₹5 Cr-₹4 Cr-₹14 L₹3 L-₹47 L₹0₹0₹0₹0₹0₹0
₹98 Cr-₹14 Cr₹44 Cr-₹175 Cr-₹308 Cr-₹350 Cr-₹609 Cr-₹641 Cr₹59 Cr₹71 Cr-₹66 Cr₹204 Cr₹18 Cr₹21 Cr₹9 Cr₹3 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)1,888.00
Volume (₹)1.80 L
High (₹)1,928.00
Upper Circuit2,036.20
Low (₹)1,874.70
Lower Circuit1,666.00
Prev Close1,854.70
52W High (₹)2,048.00
Price1,921.60
52W Low (₹)1,260.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)35248.00 Cr
Div. Yield (%)0.19
PE Ratio34.85
Debt to Equity0.24
Price to Book6.13
Book Value260.46
EPS (TTM)53.32
Face Value10.00
ROE (%)20.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
EMCURENSE
LTP
1W Low
1W High
Market cap (₹)
1903.2-16.8 (-0.87%)
1900.10
1984.80
4,56,833Cr
9158-81 (-0.88%)
9087
9467
2,45,426Cr
4844-206 (-4.08%)
4844
5066
1,87,320Cr
1131.6-59.4 (-4.99%)
1125.10
1187
1,13,217Cr
1378.5-45 (-3.16%)
1376.70
1426.10
1,12,212Cr
1843.2-95.3 (-4.92%)
1811.70
1949
1,01,155Cr
2112.6-58.9 (-2.71%)
2111.10
2192
97,626Cr
2337.6-45.3 (-1.90%)
2335
2419.20
96,859Cr
1161.6-16.4 (-1.39%)
1154.40
1179.90
96,406Cr
1656.3+11 (0.67%)
1622.60
1717
93,614Cr
1921.6+52.2 (2.79%)
1835
1928
35,248Cr

Emcure Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹534.57Cr; with other income of ₹2.07Cr, profit before interest and tax came to ₹425.06Cr. Interest expense was ₹31.54Cr; PBT before exceptional items stood at ₹393.53Cr. Cost mix (full year): raw materials ₹3829.11Cr; employee cost ₹1552.2Cr; depreciation ₹109.5Cr; other expenses ₹2047.95Cr. Basis: consolidated annual results.

Emcure Pharmaceuticals Ltd Quaterly Results Key Takeaways

Emcure Pharmaceuticals Ltd reported ₹2580.45Cr total income from operations in Jun 2026, softer than ₹2469.7Cr in Mar 2026 but higher than ₹2100.54Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹534.57Cr; with other income of ₹2.07Cr, profit before interest and tax came to ₹425.06Cr. Interest expense was ₹31.54Cr, taking profit before tax to ₹393.53Cr. After tax of ₹101.03Cr, profit after tax stood at ₹292.49Cr (vs ₹243.74Cr in Mar 2026 and ₹214.79Cr in Jun 2025).